RecruitingNCT06399302

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes: PROMISE-Lung Study

Sponsor

Duke University

Enrollment

2,600 participants

Start Date

Sep 3, 2024

Study Type

OBSERVATIONAL

Conditions

Lung Transplant; Complications Lung Transplant; Infection or Inflammation Lung Transplant Rejection Lung Transplant Failure

Summary

This project aims to collect detailed clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients at Lung Transplant Centers. The goal is to create a robust resource for various research objectives, including studying the impact of variations in donor and medical practices on clinical outcomes. The project also seeks to identify serum biomarkers associated with or predictive of specific post-transplant complications and conditions.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with lung transplant failure, lung transplant rejection, and other related conditions. The study is currently recruiting participants at 19 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(19)

University of California Los Angeles

Los Angeles, California, United States

University of California at San Francisco

San Francisco, California, United States

Stanford University Medical Center

Stanford, California, United States

University of Miami

Miami, Florida, United States

Johns Hopkins University

Baltimore, Maryland, United States

Brigham and Womens Hospital

Boston, Massachusetts, United States

University of Michigan

Ann Arbor, Michigan, United States

University of Minnesota

Minneapolis, Minnesota, United States

New York University

New York, New York, United States

Columbia University

New York, New York, United States

Duke University Medical Center

Durham, North Carolina, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Houston Methodist Hospital, Texas Medical Center

Houston, Texas, United States

Inova Fairfax Hospital

Falls Church, Virginia, United States

University of Washington

Seattle, Washington, United States

University of Wisconsin Hospital and Clinics

Madison, Wisconsin, United States

University Health Network

Toronto, Canada, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06399302

Related Trials

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

NCT0608203779 locations

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Conditions

Summary

Eligibility

Plain Language Summary

Locations(19)

Related Trials

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

CMV Immunity Monitoring in Lung Transplant Recipients

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients